ORIENTBIO Inc. (002630) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.026x

Based on the latest financial reports, ORIENTBIO Inc. (002630) has a cash flow conversion efficiency ratio of 0.026x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.77 Billion ≈ $1.20 Million USD) by net assets (₩67.73 Billion ≈ $45.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of ORIENTBIO Inc. for the company's overall valuation and market capitalisation.

ORIENTBIO Inc. - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how ORIENTBIO Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

ORIENTBIO Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ORIENTBIO Inc. ranked by their cash flow conversion efficiency. Explore earnings quality score of ORIENTBIO Inc. to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
BEML LAND ASSETS LTD NSE:BLAL	-0.017x
5E Advanced Materials Inc AU:5EA	-0.057x
Pinar Entegre Et ve Un Sanayi AS IS:PETUN	-0.017x
PT Ingria Pratama Capitalindo Tbk JK:GRIA	0.071x
Sumeeko Industries Co Ltd TWO:2066	0.070x
Vaziva Sa PA:ALVAZ	N/A
High Tech Pharm Co. Ltd KQ:106190	0.052x
IMPACT Silver Corp. V:IPT	0.014x

Annual Cash Flow Conversion Efficiency for ORIENTBIO Inc. (2007–2025)

The table below shows the annual cash flow conversion efficiency of ORIENTBIO Inc. from 2007 to 2025. View 002630 stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	₩71.85 Billion ≈ $48.69 Million	₩752.29 Million ≈ $509.82K	0.010x	-76.28%
2024-03-31	₩85.10 Billion ≈ $57.67 Million	₩3.76 Billion ≈ $2.55 Million	0.044x	+171.70%
2023-03-31	₩71.39 Billion ≈ $48.38 Million	₩1.16 Billion ≈ $786.07K	0.016x	-42.52%
2022-03-31	₩83.19 Billion ≈ $56.38 Million	₩2.35 Billion ≈ $1.59 Million	0.028x	-84.30%
2021-03-31	₩48.55 Billion ≈ $32.90 Million	₩8.74 Billion ≈ $5.92 Million	0.180x	+339.61%
2020-03-31	₩51.96 Billion ≈ $35.21 Million	₩-3.90 Billion ≈ $-2.65 Million	-0.075x	+59.21%
2019-03-31	₩62.65 Billion ≈ $42.45 Million	₩-11.54 Billion ≈ $-7.82 Million	-0.184x	-648.68%
2018-03-31	₩79.92 Billion ≈ $54.16 Million	₩-1.97 Billion ≈ $-1.33 Million	-0.025x	+52.82%
2017-03-31	₩97.94 Billion ≈ $66.38 Million	₩-5.11 Billion ≈ $-3.46 Million	-0.052x	-621.81%
2016-03-31	₩91.29 Billion ≈ $61.87 Million	₩912.43 Million ≈ $618.34K	0.010x	-58.01%
2015-03-31	₩67.35 Billion ≈ $45.64 Million	₩1.60 Billion ≈ $1.09 Million	0.024x	-32.14%
2014-03-31	₩61.85 Billion ≈ $41.91 Million	₩2.17 Billion ≈ $1.47 Million	0.035x	-57.12%
2013-03-31	₩62.29 Billion ≈ $42.21 Million	₩5.09 Billion ≈ $3.45 Million	0.082x	+71.95%
2011-03-31	₩65.49 Billion ≈ $44.38 Million	₩3.11 Billion ≈ $2.11 Million	0.048x	-68.59%
2010-03-31	₩61.77 Billion ≈ $41.86 Million	₩9.35 Billion ≈ $6.34 Million	0.151x	+347.50%
2007-03-31	₩44.86 Billion ≈ $30.40 Million	₩1.52 Billion ≈ $1.03 Million	0.034x	--

About ORIENTBIO Inc.

KO:002630 Korea Biotechnology

Market Cap

$73.37 Million

₩108.27 Billion KRW

Market Cap Rank

#20509 Global

#1129 in Korea

Share Price

₩913.00

Change (1 day)

+8.69%

52-Week Range

₩467.00 - ₩1070.00

All Time High

₩6770.89